Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Madopar
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Madopar 100mg/25mg capsules
0409010K0BBAKAJ
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 36,023 |
|
Madopar 50mg/12.5mg capsules
0409010K0BBAIAI
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 29,894 |
|
Madopar CR capsules
0409010K0BBANAF
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 20,252 |
|
Madopar 50mg/12.5mg dispersible tablets
0409010K0BBAJAM
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 18,942 |
|
Madopar 100mg/25mg dispersible tablets
0409010K0BBALAL
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 6,957 |
|
Madopar 200mg/50mg capsules
0409010K0BBAMAK
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 4,324 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.